PR
Healthcare & Life Sciences
PredictImmune
United Kingdom
PredictImmune is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About PredictImmune
Based in the United Kingdom, PredictImmune is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
PredictImmune develops diagnostic tests to predict patient response to immunotherapy treatments, aiming to personalize treatment plans for immune-mediated diseases.
Explore PredictImmune's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.